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OBJECTIVES This study evaluates the impact of obesity on coronary endothelial function in patients with
normal or mild coronary artery disease.
BACKGROUND The American Heart Association (AHA) has recently classified obesity as a modifiable risk
factor for coronary heart disease.
METHODS A total of 397 consecutive patients with normal or mildly diseased coronary arteries at
angiography underwent coronary vascular reactivity evaluation using intracoronary adenosine,
acetylcholine and nitroglycerin. Patients were divided into three groups based on the body
mass index (BMI): Group 1, patients with a BMI ,25 (n 5 117, normal weight); Group 2,
patients with a BMI 25–30 (n 5 149, overweight) and Group 3, patients with a BMI .30
(n 5 131, obese).
RESULTS There were no significant differences among the groups in regard to other cardiovascular risk
factors, except that overweight but not obese patients were significantly older than normal-
weight patients (47 6 1 years in Group 1, 53 6 1 years in Group 2 and 50 6 1 years in Group
3, p , 0.001). The percent change of coronary blood flow to acetylcholine (%D CBF Ach)
was significantly lower in the obese patients than in the normal-weight group (85.2 6 12.0%
in Group 1, 63.7 6 10.0% in Group 2 and 38.1 6 9.6% in Group 3, p 5 0.009). By
multivariate analysis, overweight (odds ratio, 1.55; 95% confidence interval, 1.2–2.0) and
obesity (odds ratio, 2.41; 95% confidence interval, 1.5–4.0) status were independently
associated with impaired coronary endothelial function.
CONCLUSIONS The study demonstrates that obesity is independently associated with coronary endothelial
dysfunction in patients with normal or mildly diseased coronary arteries. (J Am Coll Cardiol
2001;37:1523–8) © 2001 by the American College of Cardiology
Atherosclerosis is a complex chronic disease of the arteries
that may be initiated early in life and becomes more
common with increasing age (1,2). The Bogalusa autopsy
study revealed that the extent of atherosclerotic lesions in
the coronary vessels increased markedly with the presence of
multiple risk factors, including obesity, hypertension and
hypercholesterolemia (2). Patients with obesity have an
increased risk of coronary atherosclerosis. However, until
recently the role of obesity as an independent risk factor for
coronary atherosclerosis remained controversial; its relation-
ship with coronary atherosclerosis was initially viewed as
indirect, because obesity often coexists with other cardio-
vascular risk factors including hyperlipidemia, hypertension
and diabetes (3,4). In response to several long-term longi-
tudinal studies that have indicated obesity as an indepen-
dent predictor of coronary atherosclerosis (5–8), the Amer-
ican Heart Association (AHA) has reclassified obesity as a
major, modifiable risk factor for coronary heart disease
(9,10). Furthermore, Calle et al. (11) recently reported
higher total-cause and cardiovascular mortality with in-
creasing body weight in both men and women in all age
groups.
Coronary risk factors including hypercholesterolemia,
hypertension, diabetes and smoking have been shown to
cause impairment of endothelial vasodilator function in
both the epicardial and the coronary resistance arteries
(12–19). We and others have recently demonstrated an
association between coronary endothelial dysfunction and
the development of cardiac events in patients with normal or
mild coronary artery disease, underscoring the functional
significance of coronary endothelial dysfunction (20–22).
However, to date the association between obesity and
coronary endothelial function in humans with early coro-
nary atherosclerosis has not been defined. Thus, the present
study was designed to assess the association between obesity
and coronary endothelial function in patients with normal
or mild coronary artery disease.
METHODS
Study population. A total of 397 consecutive patients who
had been referred for cardiac catheterization to exclude
coronary artery disease were considered for enrollment in
the study. The decision to refer the patient for cardiac
catheterization was made at the discretion of the referring
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cardiologist. In our institution, the protocol of assessing
coronary endothelial dysfunction and coronary flow reserve
is used as a clinical practice protocol that is usually per-
formed in patients with normal or mild coronary artery
disease in consultation with the referring cardiologist (20).
Patients were included in this study if they had the follow-
ing: 1) angiographically smooth arteries; 2) mild irregular-
ities, ,30% lumen diameter stenosis by visual assessment in
any major epicardial vessel and 3) proximal coronary arteries
.2.0 mm in diameter. Patients with a history of variant
angina, documented previous myocardial infarction, acute
coronary syndromes, previous coronary artery bypass graft or
coronary intervention were excluded from this study (20).
Long-acting nitrates and calcium channel blocking agents
were both withheld for 36 to 48 h before the study to allow
for the assessment of coronary physiology in the baseline
state. The study was approved by the Mayo Clinic Institu-
tional Review Board and informed consent was obtained.
The 397 patients in this study were divided into three
groups according to their body mass index (BMI) at the
time of the study. Group 1 consisted of 117 patients who
had a BMI of ,25 (normal weight group), Group 2
consisted of 149 patients who had a BMI between 25 and
30 (overweight group) and Group 3 consisted of 131
patients who had a BMI of .30 (obese group).
Definitions. The definition of obesity is based on the BMI,
which is defined as weight in kilograms divided by height in
meters squared (kg/m2). This index is independent of
height (r 5 –0.03) and strongly related to weight (r 5 0.86)
(23). Recently the AHA has defined obesity as a BMI .30.
A BMI between 25 and 30 is considered overweight and
normal BMI ,25 (10). Patients were considered to have
systemic hypertension if they had a history of elevated blood
pressure requiring medical therapy (17).
Study protocol. Diagnostic coronary angiography was per-
formed using a 6F Judkins catheter with a standard femoral
percutaneous approach. Two thousand five hundred units of
intravenous heparin were administered at the beginning of
the procedure. Nonionic contrast material was used for all
patients. Nitroglycerin was not given before the diagnostic
procedure.
Coronary vascular reactivity responses to acetylcholine
and adenosine were studied according to a previously
reported protocol (16,17,20). After control coronary
angiograms had been obtained, a 0.014-inch Doppler
guidewire (Endosonics, Santa Ana, California) was in-
troduced within a 2.2F coronary infusion catheter into
the left anterior descending coronary artery (16). After
stable baseline flow velocities were obtained, a bolus of
intracoronary adenosine (18–42 mg) was administered for
measurement of coronary flow reserve. Time was allowed
for coronary blood flow to return to baseline, then selective
intracoronary infusion of increasing concentrations of ace-
tylcholine (1026, 1025 and 1024 mol/l) was performed for a
total of 3 min at each dose. At the end of each infusion, the
following data were obtained: electrocardiogram, Doppler
velocities and coronary angiography, heart rate and blood
pressure. After infusions of acetylcholine, 200 to 300 mg of
intracoronary nitroglycerin was given and all data were
repeated within 2 min using the same projection as the
baseline.
Quantitative coronary angiography. Analysis of artery
diameter from the cine films was done with a modification
of the technique previously described (16,17,20). An end-
diastolic still frame at each infusion (baseline, acetylcho-
line 3 3 and nitroglycerin) was selected from the angio-
graphic sequence. The absolute diameter of the vessel lumen
perpendicular to the long axis of the artery was measured by
using the 8F guide catheter as the calibration standard.
These measurements were made by experienced observers
unaware of the results of the coronary vascular reactivity
tests or BMI.
Assessment of coronary blood flow. Doppler flow velocity
spectra were analyzed online to determine time-averaged
peak velocity. Coronary flow reserve was calculated as the
ratio of hyperemic to basal average peak velocity following
adenosine administration. Volumetric coronary blood flow
(CBF) was determined from the relation: CBF 5 cross-
sectional area 3 average peak velocity 3 0.5 (24,25).
Statistical analysis. Continuous variables are summarized
as mean 6 standard error, unless otherwise indicated.
Discrete variables are presented as frequencies and percent-
ages of available data. Differences between groups were
tested using one-way analysis of variance or Pearson chi-
squared test. Pairwise comparisons were conducted using
Tukey’s Studentized range. Odds ratios adjusted for con-
ventional risk factors (age, gender, lipid levels, hypertension,
smoking status and menopausal status) were estimated by
ordinal logistic regression. A continuous relation between
BMI and percent change of coronary blood flow to acetyl-
choline was evaluated using Spearman correlation coeffi-
cient. A linear regression model between BMI and percent
change of coronary blood flow to acetylcholine with age,
glucose, high density lipoprotein, hypertension and triglyc-
erides as covariates was also assessed.
Abbreviations and Acronyms
AHA 5 American Heart Association
BMI 5 body mass index
CAD 5 coronary artery diameter
CBF 5 coronary blood flow
%D CBF Ach 5 % change of coronary blood flow in
response to acetylcholine
%D CBF NTG 5 % change of coronary blood flow in
response to nitroglycerin
CI 5 confidence intervals
HDL 5 high density lipoprotein
LDL 5 low density lipoprotein
OR 5 odds ratio
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RESULTS
Patient characteristics. Patients with normal weight were
significantly younger than those in the overweight group
(47 6 14 yrs in Group 1, 53 6 12 yrs in Group 2 and 50 6
10 yrs in Group 3) (Table 1). This significant difference in
age is primarily between the overweight and normal-weight
groups, whereas there were no significant differences be-
tween the obese and normal-weight groups. Women in the
normal-weight group were less likely to be postmenopausal
(52%, 84% and 63% respectively, p , 0.001). There was no
significant difference among the study groups with regard to
coronary risk factors, mean arterial pressure or the use of
medications (Table 1).
BMI, fasting blood glucose and serum lipids. Group 1
consisted of patients with a BMI ,25; the mean BMI was
22.2 6 0.18 kg/m2. Group 2 consisted of patients with BMI
between 25 and 30; the mean BMI was 27.4 6 0.12 kg/m2.
Group 3 consisted of patients with BMI .30; the mean
BMI was 34.7 6 0.39 kg/m2. Compared with the normal-
weight group, both the overweight and obese groups had
significantly higher levels of fasting blood glucose (91.4 6
1.3 mg%, 98.8 6 2.5 mg% and 101.8 6 2.4 mg%,
respectively, p , 0.05) and triglycerides (126.6 6 8.7 mg/dl,
159.1 6 7.7 mg/dl and 184.1 6 10.0 mg/dl, respectively,
p , 0.05). There was no statistical difference, however,
between the overweight and obese groups with regard to
these two variables. There was no difference among all three
groups with regard to fasting total cholesterol level (203 6
5 mg/dl, 218 6 4 mg/dl and 209 6 4 mg/dl). However,
compared with the normal-weight group, both the over-
weight and obese groups had slightly significantly lower
levels of HDL (59 6 2 mg/dl, 52 6 2 mg/dl and 49 6 1
mg/dl, both p , 0.001). Furthermore, there was a signifi-
cant correlation between BMI and elevated triglyceride
levels, low high density lipoprotein and fasting blood
glucose levels (p , 0.001). However, there was no evidence
of interaction between gender and BMI.
Changes in coronary blood flow. Baseline coronary blood
flow did not differ among the study groups (48.3 6
2.5 ml/min in Group 1, 52.4 6 2.9 ml/min in Group 2 and
50.4 6 3.0 ml/min in Group 3, p 5 0.61). Baseline
coronary artery diameter also did not differ among the three
groups (2.2 6 0.06 mm in Group 1, 2.25 6 0.05 mm in
Group 2 and 2.20 6 0.05 mm in Group 3, p 5 0.72).
Coronary endothelial function assessment using the percent
change in coronary blood flow in response to acetylcholine
(%D CBF Ach) demonstrated significant reduction in cor-
onary blood flow changes in the obese group compared with
the normal-weight group (85.2 6 12.0% in Group 1,
63.7 6 10.0% in Group 2 and 38.1 6 9.6% in Group 3, p 5
0.009) (Fig. 1). This difference remained significant even
after adjustment for age (p 5 0.01). However, the percent
change coronary artery diameter in response to acetylcholine
was not significantly different among the three groups
(–14.2% 6 2.6% in Group 1, –13.5 6 2.4% in Group 2 and
–15.9 6 2.5% in Group 3, p 5 0.79). Furthermore, the
coronary flow reserve to adenosine was within the normal
range among the three groups (2.88 6 0.07 in Group 1,
2.81 6 0.06 in Group 2 and 3.06 6 0.07 in Group 3). There
was no difference in percent change of coronary blood flow
in response to nitroglycerin (%D CBF NTG) among the
three groups (53 6 9.0% in Group 1, 38 6 11% in Group
Table 1. Patient Characteristics and Fasting Serum Lipids and Glucose
Characteristics
BMI < 25
(n 5 117)
25 < BMI < 30
(n 5 149)
BMI > 30
(n 5 131)
Age, yrs, mean (range) 47 (17–78) 53 (23–80)* 50 (26–82)
Male, no. (%) 37 (32) 68 (46) 47 (36)
Hypertension, no. (%) 32 (28) 49 (33) 40 (31)
Ejection fraction (mean 6 SD) 0.64 6 0.08 0.64 6 0.09 0.65 6 0.09
Diabetes, no. (%) 5 (4) 7 (5) 11 (8)
Family history, no. (%) 58 (52) 76 (52) 69 (54)
Ever smoked, no. (%) 57 (51) 75 (51) 57 (45)
Postmenopause, no. (%) 39 (52) 61 (84)* 50 (63)*
Mean arterial pressure (mm Hg) 102 6 17 105 6 15 105 6 14
Total Cholesterol, mg/dl 203 6 5 218 6 4 209 6 4
Triglycerides, mg/dl 127 6 9 159 6 8* 184 6 10*
HDL cholesterol, mg/dl 59 6 2 52 6 2 49 6 1*
LDL cholesterol, mg/dl 118 6 4 133 6 4 123 6 4
Fasting blood glucose, mg % 91 6 1 99 6 2† 102 6 2†
Medications (%)
Angiotensin-converting enzyme inhibitors 5.1 6.0 3.1
Beta-blockers 22.2 18.8 20.6
Calcium channel blockers 40.2 37.6 29.0
Lipid lowering 20.5 20.8 14.5
Antioxidants 10.2 9.4 8.6
Data presented are mean 6 SE unless otherwise indicated.
*p , 0.001 versus normal weight group; †p 5 0.005 versus normal weight group.
BMI 5 body mass index; HDL 5 high density lipoprotein; LDL 5 low density lipoprotein; SD 5 standard deviation.
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2 and 54 6 10% in Group 3). There was no correlation
between %D CBF NTG and BMI (Spearman r 5 –0.007,
p 5 0.90). By multivariate ordinal logistic regression anal-
ysis, overweight (odds ratio, 1.55; 95% confidence interval,
1.2–2.0) and obesity (odds ratio, 2.41; 95% confidence
interval, 1.5–4.0) status were independent predictors of
impaired coronary endothelial function. Similarly, a signif-
icant association between obesity and coronary endothelial
dysfunction was observed when BMI was analyzed as a
continuous variable univariately (Spearman r 5 –0.167, p 5
0.0012) and in a multivariable analysis (p 5 0.03). There
were no significant differences in the angiographic degrees
of coronary atherosclerosis among the three groups.
DISCUSSION
The current study demonstrates for the first time that
obesity is independently associated with coronary endothe-
lial dysfunction in patients with normal or mildly diseased
coronary arteries and that it is a risk factor for the progres-
sion of coronary atherosclerosis in humans. The current
study underscores the need to address obesity as a risk factor
for the development of coronary atherosclerosis. The role of
obesity as an independent risk factor for coronary athero-
sclerosis continues to emerge. The Nurses’ Health Study of
women 30 to 55 years of age who were free of cardiovascular
disease at entry revealed that the rate of cardiac mortality
among the obese women was more than twice that among
the leanest women (5). Moreover, the Health Professionals
Follow-up Study revealed BMI to be a strong predictor of
coronary heart disease. Men with BMI $33 had a relative
risk of 3.44 for coronary heart disease (8).
Coronary endothelial dysfunction is considered an early
stage of coronary atherosclerosis and may occur at the
epicardial vessels, resistance vessels or both (12–18,25). In
the current study there was no difference between the
groups in the epicardial coronary response to acetylcholine.
Moreover, there was no attenuation in the response to the
nonendothelial vasodilators, including adenosine and nitro-
glycerin. Thus, our study suggests that the primary effect of
obesity on coronary endothelial function appears to occur at
the resistance vessels. This observation is in accord with
other studies that demonstrated that coronary endothelial
dysfunction occurs at the resistance vessels before the
development of epicardial coronary artery disease (13,14).
Another possibility for this differential effect at the resis-
tance vessels may be related to the coexistence of insulin
resistance syndrome, which is associated with obesity, in our
patients (26). This possible mechanism is supported by the
correlation between BMI and other metabolic factors that
was obtained in the current study.
The current study extends recent observation of an
association between obesity and peripheral endothelial func-
tion (26–29). This association may occur through the
development of insulin resistance syndrome that is com-
monly present in obese patients and as was demonstrated by
Steinberg et al. (26). Our study also indirectly suggests an
association between obesity, insulin resistance syndrome
and coronary endothelial dysfunction, as evidenced by the
presence of elevated fasting blood glucose and triglycerides
when compared with normal-weight groups. Several other
investigators reported an association between endothelial
dysfunction and insulin resistance syndrome (30). Further-
more, Yudkin et al. (30) suggested that adipose tissue is an
important determinant of a low-level, chronic inflammatory
state reflected by increased levels of interleukin-6, tumor
necrosis factor-alpha and C-reactive protein inducing insu-
lin resistance and endothelial dysfunction. Other possible
underlying mechanisms may include the activation of the
sympathetic nervous system, activation of vasoconstrictive
peptides such as endothelin-1 and angiotensin and decreased
insulin-mediated vasodilation, all of which were found to be
associated with obesity (31). This link between obesity and
coronary endothelial dysfunction suggests a major indepen-
dent role of obesity in the progression of coronary artery
disease, as evidenced by the association between severe
endothelial dysfunction and cardiac events at follow-up in
patients with mild coronary artery disease (20–22).
Clinical implications. The current in vivo study extends
the previous epidemiologic (5–8) and autopsy (2) observa-
tions that obesity is an important independent risk factor for
the development of coronary atherosclerosis. Furthermore,
in contrast to these previous studies that have only adjusted
for limited numbers of cardiovascular risk factors, thus
making the issue of “independence” unresolved (5–8), our
study demonstrates an independent effect of obesity on
coronary endothelial function even after analysis of all
conventional cardiovascular risk factors. These data support
the recent AHA recommendations for classifying obesity as
a major modifiable risk factor for coronary atherosclerosis.
The worldwide epidemic of obesity is reaching critical
proportions. An estimated 250 million people in the world
are obese, and this number is predicted to reach 300 million
by 2050 (32). Obesity has joined the ranks of chronic
diseases that have displaced undernutrition and infectious
diseases as the major causes of death (32,33). In the developing
countries, the emerging epidemic of cardiovascular disease may
in part be explained by recent lifestyle changes resulting in
Figure 1. Mean (6 SE) of the percent change of coronary blood flow in
response to acetylcholine in the study groups. % DCBF Ach 5 % change
of coronary blood flow in response to acetylcholine.
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increased body weight (34). The increasing prevalence of
obesity will have a major effect on health care costs (35).
Obesity is a chronic disease that is present in both the
adult and the pediatric population (36), and compared to
other cardiovascular risk factors such as hypertension and
diabetes, the presence of obesity is evident to obese people
as well as to casual observers. Preventive measures are the
primary tools to slow or reverse the worldwide explosion of
obesity (32). Unfortunately, research on primary and sec-
ondary prevention of obesity is in its infancy and more
efforts are needed (10). Furthermore, no matter how effec-
tive preventive strategies may be, there will still be a large
pool of people who are already at risk of obesity and who
need treatment. Simple prevention techniques may have
major impact. The importance of modifying this risk factor
is underscored by the recent observation that exercise
training may improve coronary endothelial function (37).
Other management strategies for treatment and secondary
prevention of obesity must be appropriate and safe enough
for use by all obese people, even those who may be without
clear medical indications for intensive interventions such as
drug treatment (38).
Study limitations. Although all traditional risk factors
have been analyzed, other nontraditional risk factors includ-
ing homocysteine levels have not been adjusted for. Second,
this is a cross-sectional study and its findings may warrant
confirmation through a prospective study. Third, because
this study was conducted in patients undergoing coronary
angiography, selection bias cannot be ruled out in that
physicians might be reluctant to refer these patients for
coronary angiography until their symptoms are advanced.
Fourth, other measures of adiposity such as waist-hip ratios
were not measured.
Conclusions. This in vivo study demonstrates for the first
time that obesity is independently associated with coronary
endothelial dysfunction in patients with normal or mildly
diseased coronary arteries. This study supports a role for
obesity as an independent risk factor for the development of
coronary atherosclerosis in humans.
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